The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson… - Journal of Antimicrobial …, 2013 - academic.oup.com
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
The enhanced permeability retention effect: a new paradigm for drug targeting in infection.
EA Azzopardi, EL Ferguson… - The Journal of …, 2012 - europepmc.org
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
[PDF][PDF] The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson… - J Antimicrob …, 2013 - researchgate.net
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
The enhanced permeability retention effect: a new paradigm for drug targeting in infection.
EA Azzopardi, EL Ferguson, DW Thomas - 2013 - cabidigitallibrary.org
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
[PDF][PDF] The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson… - J Antimicrob …, 2013 - scholar.archive.org
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson, DW Thomas - 2013 - um.edu.mt
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
[引用][C] The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson… - Journal of Antimicrobial …, 2013 - hero.epa.gov
The enhanced permeability retention effect: a new paradigm for drug targeting in infection |
Health & Environmental Research Online (HERO) | US EPA Jump to main content US EPA …
Health & Environmental Research Online (HERO) | US EPA Jump to main content US EPA …
[引用][C] The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson, DW Thomas - Journal of Antimicrobial …, 2012 - cir.nii.ac.jp
The enhanced permeability retention effect: a new paradigm for drug targeting in infection |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
EA Azzopardi, EL Ferguson… - Journal of Antimicrobial …, 2013 - orca.cardiff.ac.uk
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity,
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …
mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of …